Can Non-alcoholic fatty liver disease (NAFLD) as a marker for microalbuminuria in prediabetes group?

نویسندگان

  • Anjaneya Prasad
  • Pradeep Babu
چکیده

Objective: Non – alcoholic fatty liver disease (NAFLD) is an imageological entity without elevation of liver enzymes. The purpose of this case – control study was to corelate microalbuminuria to Prediabetes with and without NAFLD. Method: This study was done at the Department of Medicine,DR. PSIMS & RF Chinaoutpally, A.P. India between Jan 2012 to Dec 2012. 200 patients (100 cases, 100 controls) above 18 years of age were included in this study. The microalbuminuria reference range was 30 – 300mg/day. Results: Microalbuminuria levels were found to be significantly higher in Prediabetes patients with non alcoholic fatty liver disease than prediabetes alone.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

سطح سیتوکراتین 18، فعالیت آنزیم پاراکسوناز و پروفایل لیپیدی در بیماران کبد چرب غیرالکلی در ایران

Background: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease is increasing in adults and children worldwide. Obesity, insulin resistance or diabetes type II, hyperlipidemia and hypertriglyceridemia plays a major role in the epidemiology of this disease. Cytokeratin 18 (CK-18) the major intermediate filament protein in the liver is a marker of increased hepatocyte apoptosis. ...

متن کامل

Comparing Effects of Medication Therapy and Exercise Training with Diet on Liver enzyme Levels and Liver Sonography in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

Background & Objectives: Non-alcoholic fatty liver disease, characterized by the deposition of fat in liver cells, can cause fibrosis, cirrhosis, and liver cell damage if not controlled. The aim of this study is to compare the effects of medication therapy and exercise training with diet on liver enzyme levels and liver sonography in patients with non-alcoholic fatty liver disease (NAFLD). Mate...

متن کامل

Evaluation of Serum Chemerin and Lipid accumulation product as Predictors of Non-Alcoholic Fatty Liver Disease in Simple Obese Egyptian Children

Background The increase in the prevalence of obesity worldwide has led to non-alcoholic fatty liver disease (NAFLD) becoming one of the most common causes of chronic liver disease. Chemerin is a novel adipokine which regulates adipogenesis which is also a marker of systemic and vascular inflammation. Lipid accumulation product (LAP) is associated with the presenc...

متن کامل

Effectiveness of Co-Administration of Camelina Oil and Caloric Restriction on Cardiometabolic Risk Factors, Liver Function and Mental Health in Patients with Non-Alcoholic Fatty Liver Disease: A Blinded Randomized Controlled Trial Protocol

Background: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease (CLD). Omega-3 fatty acids and antioxidants co-supplementation have been considered as an alternative treatment in NAFLD. This trial will evaluate camelina sativa oil (CSO) effects as a rich source of omega-3 fatty acids and antioxidants on cardiometabolic risk factors, metabolic endotoxemia, liver en...

متن کامل

Evaluation of the effects of resveratrol on non-alcoholic fatty liver disease A systematic review study

Introduction: Non-alcoholic fatty liver disease (NAFLD) is a condition in which triglycerides accumulate in liver cells without a history of alcohol consumption. Evidence has shown that auxiliary treatments, including the use of antioxidant compounds, can be effective in improving nonalcoholic fatty liver. Resveratrol is an antioxidant compound that has been shown to be beneficial in some disea...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2013